Airway epithelium-derived transforming growth factor-β is a regulator of fibroblast proliferation in both fibrotic and normal subjects
Autor: | Michael Roth, Franco Gambazzi, Judith L. Black, Michael Tamm, Pieter Borger, Janette K. Burgess, Katrin Hostettler, Mikael Gencay |
---|---|
Rok vydání: | 2008 |
Předmět: |
Pulmonary Fibrosis
Mesenchyme Blotting Western education Immunology Enzyme-Linked Immunosorbent Assay Respiratory Mucosa Biology Cell–cell interaction Transforming Growth Factor beta Fibrosis Pulmonary fibrosis medicine Humans Immunology and Allergy Fibroblast Cells Cultured Cell Proliferation Transforming growth factor beta Fibroblasts respiratory system medicine.disease Epithelium respiratory tract diseases medicine.anatomical_structure Cancer research biology.protein Respiratory epithelium |
Zdroj: | Clinical & Experimental Allergy. 38:1309-1317 |
ISSN: | 1365-2222 0954-7894 |
Popis: | In the healthy lung, airway epithelial cells (AEC) regulate fibroblast proliferation through release of soluble factors, such as prostaglandins and proteins. Fibroproliferative diseases and airway remodelling may result from an inadequate generation of suppressive factors by AEC or the inability of fibroblasts to respond to them appropriately.The aim of this study was to study the effect of primary human AEC on the proliferation of fibroblasts obtained from healthy and fibrotic lungs in an interactive cell culture model.Conditioned medium (CM) from 14 out of 16 AEC lines significantly inhibited proliferation of normal human lung fibroblasts by 51.2+/-6.0%. The proliferation of fibroblasts derived from patients with lung fibrosis was equally inhibited by CM of AEC. The inhibitory effect of AEC-CM was completely reversed when fibroblasts were pre-incubated with 2.5 microm indomethacin. Furthermore, primary human AEC, but not fibroblasts, secrete TGF-beta, and the inhibitory effect of the AEC-CM was blocked by neutralizing anti-TGF-beta antibodies.These results demonstrate that AEC actively inhibit the proliferation of both normal and fibrotic fibroblasts via TGF-beta, which induces the prostaglandin E(2) synthesis in fibroblasts. The data indicate that proliferative lung diseases may be treated using the epithelial cell as the target of medication. |
Databáze: | OpenAIRE |
Externí odkaz: |